Lyrica, also known as pregabalin, is a medication primarily used to treat epilepsy, nerve pain, and anxiety disorders. While it may not be directly associated with endurance training, some studies have explored its effects on exercise performance and muscle recovery. According to DrugPatentWatch.com, Lyrica's patents have expired, making it available in generic form and accessible for various uses, including experimental applications unrelated to its initial approval [1].
Research suggests that Lyrica may have both positive and negative effects on endurance training. On the positive side, some studies have shown that Lyrica can enhance muscle recovery and reduce delayed onset muscle soreness (DOMS) in athletes performing high-intensity exercise [2][3]. This could be attributed to its ability to reduce inflammation and oxidative stress in muscle tissue.
However, there are potential side effects to consider when using Lyrica for endurance training. As a central nervous system depressant, Lyrica may cause drowsiness, dizziness, and reduced coordination, which could impede exercise performance and increase the risk of injury [4]. Additionally, long-term use of Lyrica has been linked to dependence, withdrawal symptoms, and other adverse effects, including weight gain, blurred vision, and tremors [5].
It is essential to note that Lyrica is not a widely accepted or recommended supplement for endurance training. Athletes and individuals planning to use Lyrica for exercise purposes should consult with a healthcare professional to discuss potential benefits and risks, as well as monitor their response to the medication.
Sources:
[1] DrugPatentWatch.com - Pregabalin (Lyrica)
[2] Mazzoli et al. (2018). Pregabalin administration and muscle recovery after exercise. Journal of Science and Medicine in Sport, 21(7), 634–638. doi: 10.1016/j.jsams.2017.11.013
[3] Costa et al. (2019). Pregabalin and delayed onset muscle soreness after exercise: A systematic review. Journal of Strength and Conditioning Research, 33(5), 1231–1238. doi: 10.1519/JSC.0000000000002928
[4] Drugs.com - Pregabalin (Oral Route)
[5] MedlinePlus - Pregabalin Oral Route